Skip to content

Adaptive Biotechnologies ADPT Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$24.69M-6.0%
GeneDx Holdings logo
GeneDx HoldingsWGS
$34.65M+39.3%
Veracyte logo
VeracyteVCYT
$35.87M-24.7%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$51.66M+96.0%
Guardant Health logo
Guardant HealthGH
Natera, Inc. logo
Natera, Inc.NTRA

Other financials

Income statement

See full
Revenue$70.9M+35.1%
Gross profit$52.2M+47.1%
Operating income-$19.2M+35.1%
Net income-$20.0M+32.9%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$77.6M+53.2%
Total debt$208.2M-5.6%
Total equity$216.3M+13.6%
Total assets$505.9M-1.0%

Cash flow

See full
Operating cash flow-$9.5M+66.5%
CapEx$796.0K-36.8%
Free cash flow-$10.3M+65.3%

Valuation

See full
Market cap$2.76B+93.6%
Enterprise value$2.89B+78.0%
P/S9.3×+1.8×

Profitability

See full
Gross margin75.3%+12.7pp
Operating margin-15.8%-7.0pp
Net margin-16.8%-7.3pp
FCF margin-10.5%-4.6pp

Returns & leverage

See full
Return on equity-24.4%-9.2pp
Debt / equity-0.2×
Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adaptive Biotechnologies's operating lease ROU assets?
Adaptive Biotechnologies (ADPT) reported operating lease ROU assets of $40.25M in Q1 2026.
How has Adaptive Biotechnologies's operating lease ROU assets changed year-over-year?
Adaptive Biotechnologies's operating lease ROU assets decreased by 8.5% year-over-year, from $44M to $40.25M.
What is the long-term trend for Adaptive Biotechnologies's operating lease ROU assets?
Over 5 years (2020 to 2025), Adaptive Biotechnologies's operating lease ROU assets has grown at a -16.4% compound annual growth rate (CAGR), from $99.35M to $40.62M.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.